Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|November 28, 2018
Evaluation of neomycin analogues for HIV-1 RRE RNA recognition identifies enhanced activity simplified neamine analoguesBinto Simon, Claire Walmsley, Victoria J Jackson, et al.Beilstein Journal of Organic Chemistry|November 2, 2011
Manganese dioxide mediated one-pot synthesis of methyl 9H-pyrido[3,4-b]indole-1-carboxylate: Concise synthesis of alangiobussinineJessica Baiget, Sabin Llona-Minguez, Stuart Lang, et al.The Journal of Biological Chemistry|December 13, 2017
Differential control of Toll-like receptor 4-induced interleukin-10 induction in macrophages and B cells reveals a role for p90 ribosomal S6 kinasesRuhcha V Sutavani, Iain R Phair, Rebecca Barker, et al.Organic Letters|December 6, 2002
Pyrrolidine-5,5-trans-lactams. 1. Synthesis and incorporation into inhibitors of hepatitis C virus NS3/4A proteaseDavid M Andrews, Seb J Carey, Helene Chaignot, et al.Organic Letters|December 6, 2002
Pyrrolidine-5,5-trans-lactams. 2. The use of X-ray crystal structure data in the optimization of P3 and P4 substituentsDavid M Andrews, Helene Chaignot, Barry A Coomber, et al.Bioorganic & Medicinal Chemistry Letters|November 7, 2002
Design and synthesis of ethyl pyrrolidine-5,5-trans-lactams as inhibitors of hepatitis C virus NS3/4A proteaseMartin J Slater, David M Andrews, Graham Baker, et al.Organic Letters|November 25, 2003
Pyrrolidine-5,5-trans-lactams. 4. Incorporation of a P3/P4 urea leads to potent intracellular inhibitors of hepatitis C virus NS3/4A proteaseMartin J Slater, Elizabeth M Amphlett, David M Andrews, et al.Bioorganic & Medicinal Chemistry Letters|February 3, 2007
Studies on acyl pyrrolidine inhibitors of HCV RNA-dependent RNA polymerase to identify a molecule with replicon antiviral activityGeorge Burton, Thomas W Ku, Thomas J Carr, et al.European Journal of Medicinal Chemistry|May 17, 2003
The design of potent, non-peptidic inhibitors of hepatitis C proteaseDavid M Andrews, Helene M Chaignot, Barry A Coomber, et al.Organic Letters|November 25, 2003
Pyrrolidine-5,5-trans-lactams. 5. Pharmacokinetic optimization of inhibitors of hepatitis C virus NS3/4A proteaseDavid M Andrews, Michael C Barnes, Mike D Dowle, et al.Pageof 3